BUILDING ON TRUST AND COLLABORATION TO ROADMAP NEXT PHASE OF AUSTRALIA’S VACCINE SUCCESS Conference returns to lead charge in strengthening the entire life cycle of vaccine development
With
Leah Goodman
Chief Executive Officer
Biointelect
SEGMENT
Filmed in Sydney | September 2026
Trust, collaboration and a stronger vaccine ecosystem were the focus of the second Australian Vaccine Value Chain Conference, held in Sydney, September 2026 and hosted by life science consultancy Biointelect. More than 200 leaders from government, industry, academia, research, investment and the immunisation community attended, joined by international representatives including the International Vaccine Institute and the Coalition for Epidemic Preparedness Innovations.
The conference took place amid falling global immunisation rates, rising misinformation, shrinking funding and a resurgence of measles. In Australia, childhood immunisation rates have fallen by between 2.3 and 4.3 percentage points at standard age milestones each year since 2020. Discussions covered research funding, regional health security, sovereign manufacturing, data and capacity building, vaccine access, uptake resistance and pandemic preparedness. Delegates noted progress through the new Australian Centre for Disease Control and the updated National Immunisation Strategy, but experts say further action is needed.
In an interview with the Australian Health Journal, Biointelect CEO Leah Goodman said the mood had shifted since the inaugural 2024 conference, when nervousness was evident. This year, she said, attendees were “feeling that they had a role to play in the shaping of the Australian ecosystem.” She pointed to the first six companies announced in the Biointelect Venturer incubator, funded through the Medical Research Future Fund, as a sign of progress.
Goodman also stressed the importance of international cooperation, stating that “no country can build a resilient vaccine ecosystem alone.” A white paper will capture the discussions and set priorities for the next two years.
Source: Adapted from Biointelect media release (September 2026) and transcript
You Might also like
-
Peak body in child and family services urges prioritising healthcare for kids in care
The Centre for Excellence in Child and Family Welfare (the Centre) is calling on the Australian Government to prioritise healthcare access for children in out-of-home care.
“We have many amazing young people in care with huge potential, but they’re not set up for success,” said Deb Tsorbaris, CEO “Young people and workers tell us that access to health and education assessments is a huge disadvantage.”
-
Australian Healthcare Week Hospitals and Clinics New Content Patient Experience Planning, Culture and Growth
Sonia Marshall – South Western Sydney Local Health District
South Western Sydney Local Health District serves nearly 1 million people in a rapidly growing area of Sydney. Currently 250-300 families a week are moving into the region and with a growing population, the health district requires well executed strategy and delivery of healthcare to the population. Executive Director Sonia Marshall spoke with Australian Health Journal reporter Anne Dao at last week’s Australian Healthcare Week in Sydney, on supporting staff and the community. Sonia highlights the mission of delivering Safe Quality Healthcare at all times. In-time patient feedback is important and the SWSLHD has implemented a system called “My Experience Matters” to give near immediate response from patients on their level of care, whilst they are still on site at the hospital. The aim of the initiative is to quickly identify bad experiences that could be rectified.
Post Views:
3,923 -
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.